Fed. Circ. Upholds Allergan Win Over Lumigan Patent
The Federal Circuit on Monday ruled in favor of specialty pharmaceutical company Allergan Inc., affirming a district court's ruling that two generic-drug makers would infringe on Allergan's patent if they continued...To view the full article, register now.
Already a subscriber? Click here to view full article